Modulators of the function of FAS/AP01 receptors

Details Modulators of the function of FAS/AP01 receptors Modulators of the function of FAS/AP01 receptors

2006-09-19

2006-09-19

Romeo, David (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S252300, C435S254110, C435S320100, C435S325000, C530S350000, C536S023500, C514S012200

Reexamination Certificate

active

07108999

ABSTRACT:
Proteins capable of modulating the function of FAS/APO1 are provided. The proteins may be prepared by culturing a host cell transformed with a vector containing the DNA encoding such a protein under suitable conditions and isolating the protein.

REFERENCES:
patent: WO 93/09218 (1993-05-01), None
patent: WO96/12735 (1996-05-01), None
patent: WO96/30404 (1996-10-01), None
patent: WO96/31603 (1996-10-01), None
patent: WO96/36730 (1996-11-01), None
Marshall E. Gene therapy's growing pains. Science. Aug. 25, 1995;269(5227):1050-5.
Blau et al. Gene therapy—a novel form of drug delivery. N Engl J Med. Nov. 2, 1995;333(18):1204-7.
Branch AD. A good antisense molecule is hard to find. Trends Biochem Sci. Feb. 1998;23(2):45-50.
Jen et al. Supression of gene expression by targeted disruption of messenger RNA: available options and current strategies. Stem Cells. 2000;18(5):307-19.
Clement et al, “Fas and Tumor Necrosis Factor Receptor mediated Cell Death: Similarities and Distinctions”,J. Exp. Med., vol. 180, pp. 557-567, Aug. 1994.
Song et al, “Aggregation of the Intracellular Domain of the Type 1 Tumor Necrosis Factor Receptor Defined by the Two-hybrid System”,The J. of Biol. Chemistry, vol. 269(36), pp. 22492-22495, 1994.
Itoh et al, “A novel protein domain required for apoptosis”,Journal of Biological Chemistry, vol. 268, No. 15, pps. 10932-10937 (May 25, 1993).
Nagata et al, “Fas and Fas ligand: A death factor and its receptor”,Advances in Immunology, vol. 57, pp. 129-144 (Jan. 1, 1994).
GenBank Accession No. Q15121, “Astrocytic phosphoprotein”, Nov. 1, 1997.
GenBank Accession No. X86809, “H. sapiensmRNA for major astrocytic phosphoprotein PEA-15”, Jul. 23, 1996.
GenBank Accession No. P25445, “FASL Receptor precursor (apoptosis-mediating surface antigen FAS) (APO-1 Antigen) (CD95 Antigen)”; May 1, 1992.
GenBank Accession No. P16157, “Ankyrin 1 (Erythrocyte Ankyrin)”; Apr. 1, 1990.
GenBank Accession No. P08138, “Low-affinity nerve growth factor receptor precursor (NGF receptor)”, Aug. 1, 1988.
GenBank Accession No. P19438, “Tumor necrosis factor recptor 1 precursor (Tumor necrosis factor binding protein 1)”, Feb. 1, 1991.
GenBank Accession No. NP—002459; “Myeloid differentiation primary response gene (88)”, Mar. 19, 1999.
GenBank Accession No. P22366; “Myeloid differentiation primary response protein MYD88”; Aug. 1, 1991.
GenBank Accession No. P53355; “Death-associated protein kinase 1 (DAP kinase 1)”, Oct. 1, 1996.
Baker et al., “Transducers of life and death:TNF receptor superfamily and associated proteins.”, ONCOGENE, vol. 12, No. 1, pps. 1-9 (Jan. 4, 1996).
Boldin et al., “A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.”, Journal of Biological Chemistry, vol. 270, No. 14, pp. 7795-7798 (1995).
Chinnaiyan et al., “FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.”, CELL, vol. 81, pp. 505-512 (May 19, 1995).

Affiliated with

Also associated with

Rating

Modulators of the function of FAS/AP01 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of the function of FAS/AP01 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of the function of FAS/AP01 receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3562677